Clinical Trials Browser

Phase 4 × Withdrawn × Paclitaxel × Clear all

NCT01156961 2016-11-02

A Study of The Safety Profile of First-line Avastin (Bevacizumab) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Her2-negative Breast Cancer (AVATAX)

Phase 4 Withdrawn

Breast Neoplasms